169 related articles for article (PubMed ID: 12433438)
1. Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A.
El-Shabouri MH
Int J Pharm; 2002 Dec; 249(1-2):101-8. PubMed ID: 12433438
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticles.
Lai J; Lu Y; Yin Z; Hu F; Wu W
Int J Nanomedicine; 2010 Feb; 5():13-23. PubMed ID: 20161984
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of oral bioavailability of cyclosporine A: comparison of various nanoscale drug-delivery systems.
Wang K; Qi J; Weng T; Tian Z; Lu Y; Hu K; Yin Z; Wu W
Int J Nanomedicine; 2014; 9():4991-9. PubMed ID: 25378925
[TBL] [Abstract][Full Text] [Related]
4. pH-sensitive nanoparticles for improving the oral bioavailability of cyclosporine A.
Dai J; Nagai T; Wang X; Zhang T; Meng M; Zhang Q
Int J Pharm; 2004 Aug; 280(1-2):229-40. PubMed ID: 15265562
[TBL] [Abstract][Full Text] [Related]
5. Bioavailability and pharmacokinetics of cyclosporine A-loaded pH-sensitive nanoparticles for oral administration.
Wang XQ; Dai JD; Chen Z; Zhang T; Xia GM; Nagai T; Zhang Q
J Control Release; 2004 Jul; 97(3):421-9. PubMed ID: 15212874
[TBL] [Abstract][Full Text] [Related]
6. Studies on the cyclosporin A loaded stearic acid nanoparticles.
Zhang Q; Yie G; Li Y; Yang Q; Nagai T
Int J Pharm; 2000 May; 200(2):153-9. PubMed ID: 10867245
[TBL] [Abstract][Full Text] [Related]
7. [Preparation of cyclosporine A pH sensitive nanoparticles and oral pharmacokinetics in rats].
Dai JD; Wang XQ; Zhang T; Meng M; Zhang X; Lü WL; Zhang Q
Yao Xue Xue Bao; 2004 Dec; 39(12):1023-7. PubMed ID: 15813034
[TBL] [Abstract][Full Text] [Related]
8. Positively-charged microemulsion for improving the oral bioavailability of alendronate: in-vitro and in-vivo assessment.
Meng J; Hu L
J Pharm Pharmacol; 2011 Mar; 63(3):400-8. PubMed ID: 21749388
[TBL] [Abstract][Full Text] [Related]
9. Stable bioavailability of cyclosporin A, regardless of food intake, from soft gelatin capsules containing a new self-nanoemulsifying formulation.
Yang SG; Kim DD; Chung SJ; Shim CK
Int J Clin Pharmacol Ther; 2006 May; 44(5):233-9. PubMed ID: 16724578
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporin nanoparticulate lipospheres for oral administration.
Bekerman T; Golenser J; Domb A
J Pharm Sci; 2004 May; 93(5):1264-70. PubMed ID: 15067702
[TBL] [Abstract][Full Text] [Related]
11. Preparation and in vitro and in vivo characterization of cyclosporin A-loaded, PEGylated chitosan-modified, lipid-based nanoparticles.
Zhang L; Zhao ZL; Wei XH; Liu JH
Int J Nanomedicine; 2013; 8():601-10. PubMed ID: 23429854
[TBL] [Abstract][Full Text] [Related]
12. Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystals.
Müller RH; Runge S; Ravelli V; Mehnert W; Thünemann AF; Souto EB
Int J Pharm; 2006 Jul; 317(1):82-9. PubMed ID: 16580159
[TBL] [Abstract][Full Text] [Related]
13. Long-term studies on the stability and oral bioavailability of cyclosporine A nanoparticle colloid.
Wang XQ; Huang J; Dai JD; Zhang T; Lü WL; Zhang H; Zhang X; Wang JC; Zhang Q
Int J Pharm; 2006 Sep; 322(1-2):146-53. PubMed ID: 16787721
[TBL] [Abstract][Full Text] [Related]
14. Improvement of cyclosporine A bioavailability by incorporating ethyl docosahexaenoate in the microemulsion as an oil excipient.
Hirunpanich V; Sato H
Eur J Pharm Biopharm; 2009 Oct; 73(2):247-52. PubMed ID: 19560537
[TBL] [Abstract][Full Text] [Related]
15. Readily restoring freeze-dried probilosomes as potential nanocarriers for enhancing oral delivery of cyclosporine A.
Guan P; Lu Y; Qi J; Wu W
Colloids Surf B Biointerfaces; 2016 Aug; 144():143-151. PubMed ID: 27085046
[TBL] [Abstract][Full Text] [Related]
16. [Relative bioavailability of cyclosporine A-loaded hydroxypropyl methylcellulose phthalate nanoparticles for oral administration in rats].
Wang XQ; Dai JD; Zhang Q; Zhang T; Xia GM
Yao Xue Xue Bao; 2004 Jun; 39(6):463-6. PubMed ID: 15491107
[TBL] [Abstract][Full Text] [Related]
17. [Study on preparation conditions for polylactide nanoparticles loaded cyclosporine A and its oral bioavailability in rats].
Wang XQ; Zhang T; He Y; Zhang L; Zhang Q
Yao Xue Xue Bao; 2004 Jan; 39(1):68-71. PubMed ID: 15127586
[TBL] [Abstract][Full Text] [Related]
18. Improved dose linearity of cyclosporine pharmacokinetics from a microemulsion formulation.
Mueller EA; Kovarik JM; van Bree JB; Tetzloff W; Grevel J; Kutz K
Pharm Res; 1994 Feb; 11(2):301-4. PubMed ID: 8165192
[TBL] [Abstract][Full Text] [Related]
19. Preparation of an alternative freeze-dried pH-sensitive cyclosporine A loaded nanoparticles formulation and its pharmacokinetic profile in rats.
Yang ZQ; Xu J; Pan P; Zhang XN
Pharmazie; 2009 Jan; 64(1):26-31. PubMed ID: 19216227
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic behavior of cyclosporin A in rabbits by oral administration of lecithin vesicle and Sandimmun Neoral.
Guo J; Ping Q; Chen Y
Int J Pharm; 2001 Mar; 216(1-2):17-21. PubMed ID: 11274802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
